夢網集團(002123.SZ):擬捐贈600萬元現金及服務產品用於支持新冠病毒肺炎疫情防控
格隆匯2月3日丨夢網集團(002123.SZ)公佈,當前,新型冠狀病毒肺炎疫情防控形勢嚴峻,公司高度關注疫情發展,在做好自身防控工作的同時,為更積極履行上市公司社會責任、回饋社會,公司下設深圳市夢網慈善基金會於2020年2月2日分別與武漢市金銀潭醫院、華中科技大學同濟醫學院附屬協和醫院、黃岡市中心醫院(大別山區域醫療中心醫院)簽署《項目捐贈協議書》,擬通過發起“夢網醫護救助”項目,向上述三家醫院捐贈300萬元現金(其中100萬元現金來自於公司控股股東、實際控制人余文勝出資),及300萬元雲通信服務產品(夢網視信雲會議、通知王),共計價值人民幣600萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.